tweetindex
PT

Hüseyin S. Bozkurt,MD,AGAF

@HSEYNSANCARBOZ1 · joined 28 Oct 2020

3 awards,3 continent about Bifido 1- @AmerGastroAssn 2- @my_UEG 3-Korean Gastro Society. Bifido Algorithm Solver . Founder of Bioprobif, USA 🇺🇸 O-1A owner.

16 637Followers
163Following
4 968Posts total
108.3KViews on collected posts

Posts recentes

https://t.co/Cxkq7VG1GV 🇧🇷 Kanalizasyon 🕳️ arıtma sonucu kalan çamurdan gübre elde edip kullanmaya başladı 👏👏👏 Biz mi? Yıllar önceki çözüm projelerimizi gebze @Tubitak anlattığımızda onlara mı anlatıyoruz , duvara mı anlatıyoruz anlayamadık…. halen çamuru atıyorlar veya https:/ 758 views · 4 likes · 4 reposts · 0 replies Open on X →
🤖 AI 👉Matematik 🧬Biyoloji 👇 Stable Biopolymeric Structure (Abiogenesis) + H⁺/OH⁻ (pH Gradient → Unstable Zeta Potential → Electrochemical Reaction) = Biogenesis Yani kısaca 👉Fizik+Matematik+Kimya Her kim , yapay zeka “ilaç,tedavi” buldu/yaptı derse, arkasında gerçek 836 views · 6 likes · 3 reposts · 0 replies Open on X →
@YannickBuccella It is based on "unstable zeta potential"/“unstable entropy"—concepts from physics that underpin biology. This is a situation that this AI could never resolve on its own 1K views · 4 likes · 1 reposts · 0 replies Open on X →
Pankreas kanserinde çok sınırlı kullanımı olabilecek ve aylık 40.000 💵 maliyetli KRAS tedavisi ne yazık ki Akciğer 🫁 kanserinden sonra Kolon kanserindede geri çekildi ( tıpkı mRNA bazlı tedavi gibi) Epigenetik faktörler artık mutasyonel faktörlerden çok daha baskın 9.7K views · 33 likes · 3 reposts · 0 replies Open on X →
@GIMedOnc The likelihood of success for any treatment (including chemotherapy) that does not take dysbiosis into account is very low. 11.9K views · 7 likes · 1 reposts · 0 replies Open on X →
And just like that, adagrasib + cetuximab is no longer FDA approved for KRAS G12C colorectal cancer. The accelerated approval was officially withdrawn September 1 after KRYSTAL-10 failed to confirm benefit. We talked about KRYSTAL-10 when it was presented earlier this year. 47.4K views · 112 likes · 41 reposts · 12 replies Open on X →
👏👏👏 572 views · 0 likes · 1 reposts · 0 replies Open on X →
@YannickBuccella Oncology in CRC management is the fourth stage; unfortunately, any cancer treatment method that fails to account for intestinal dysbiosis will yield negative results. 4.2K views · 6 likes · 2 reposts · 0 replies Open on X →
@HSEYNSANCARBOZ1 hocam merhaba, randevu için sitenizdeki mail adresinizden iletişim kurmaya çalıştım ancak mail geçersiz gözüküyor. Konu hakkında size nasıl ulaşabilirim acaba? 33 views · 0 likes · 0 reposts · 0 replies Open on X →
https://t.co/2vtX7PUtBN 31.8K views · 29 likes · 2 reposts · 1 replies Open on X →
Bifidobakterinin 2 gücü : 1- mikroplastiklerin tamamen yok edilmesi 2-İnanılmaz biohybrid malzeme özelliği … İşte örnek : 1 tonluk mikroplastik biodegradasyonu sonucu kalan su 💧 yu tarım ve ziraate kazandırmanın yanında biodegradasyon sonucu 400 kg lık potansiyel gübre ++ https:/ 0 views · 11 likes · 5 reposts · 1 replies Open on X →

Em comparação com contas do mesmo porte

9 posts dos últimos 90 dias, ao lado da faixa de 10K–100K seguidores. aparece para muita gente, mas poucos desses espectadores reagem.

Mediana de visualizações1 033esta conta1 059mediana para 10K–100K
Alcance, %6.21%esta conta3.82%mediana para 10K–100K
Engajamento, %0.36%esta conta1.69%mediana para 10K–100K
MétricaEsta contaMediana para 10K–100KProporção
Mediana de visualizações por post1 0331 0590.98×
Alcance (visualizações ÷ seguidores)6.21%3.82%1.63×
Taxa de engajamento0.36%1.69%0.21×

Outras contas desta faixa →   Comparar com outra conta →   Como estas referências são construídas →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

31.8K31 Jan
3314 Jul
4.2K29 Aug
5724 Sep
47.4K5 Sep
11.9K
9.7K
1K6 Sep
836
758

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.10%31 Jan
0.00%14 Jul
0.21%29 Aug
0.17%4 Sep
0.36%5 Sep
0.08%
0.39%
0.48%6 Sep
1.08%
1.06%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.69%.

What the audience does

Likes57.4%201 in total
Reposts16.6%58 in total
Replies3.7%13 in total
Quotes2.3%8 in total
Bookmarks20.0%70 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Contas semelhantes